Simcere Zaiming is a pharmaceutical company specializing in oncology, and a subsidiary of Simcere Pharmaceutical Group Limited, that focuses on the R&D, production and commercialization of innovative cancer therapeutics. The company was formed in 2023 and is committed to solving unmet clinical needs for cancer patients in China and around the world by developing breakthrough treatments. Simcere Zaiming has an innovative R&D pipeline with differentiated clinical value, among which 15 assets are currently in clinical trials. In addition to the company’s R&D portfolio, Simcere Zaiming is marketing three innovative drugs, COSELA®, Endostar®, and Envafolimab®. By collaborating with partners globally, Simcere Zaiming strives to bring potentially new innovative therapeutics to cancer patients worldwide.
View Top Employees from Simcere Zaiming| Employees | 27 (2 on RocketReach) |
| Founded | 2023 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular Simcere Zaiming employee's phone or email?
Simcere Zaiming Questions
2 people are employed at Simcere Zaiming.
Top Simcere Zaiming Employees
Related Companies
